MDR tuberculosis--critical steps for prevention and control.
about
European union standards for tuberculosis careHospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study.Size and usage patterns of private TB drug markets in the high burden countriesMultidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristicsCost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in ChinaMajor Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin AmericaDrug-resistant tuberculosis control in China: progress and challengesPrognostic factors in tuberculosis related mortalities in hospitalized patients.Towards understanding the drivers of policy change: a case study of infection control policies for multi-drug resistant tuberculosis in South AfricaDisease appearance and evolution against a background of climate change and reduced resources.A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town.Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China.Incidence rates and deaths of tuberculosis in HIV-negative patients in the United States and Germany as analyzed by new predictive model for infectionSelected culture and drug-susceptibility testing methods for drug-resistant Mycobacterium tuberculosis screening in resource-constrained settings.Resistance of Mycobacterium tuberculosis to antibiotics in Lao PDR: first multicentric study conducted in 3 hospitals.Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.Tuberculosis of the neuromusculoskeletal system: a review of two cases presenting as chiropractic patients.Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion.GeneXpert--a game-changer for tuberculosis control?Tuberculosis and rifampicin resistance among migrants in kyrgyzstan: detection by a new diagnostic test.Evaluation of tuberculosis infection control measures implemented at primary health care facilities in Kwazulu-Natal province of South Africa.Towards tuberculosis elimination: an action framework for low-incidence countriesTuberculous scrofula: Belfast experienceRecent developments in the epidemiology and management of tuberculosis - new solutions to old problems?Prevalence of Tuberculosis, Drug Susceptibility Testing, and Genotyping of Mycobacterial Isolates from Pulmonary Tuberculosis Patients in Dessie, EthiopiaPathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.Health system delay in treatment of multidrug resistant tuberculosis patients in Bangladesh.Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal.Training laboratory technicians from the Ethiopian periphery in the MODS technique enables rapid and low-cost diagnosis of Mycobacterium tuberculosis infection.Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South AfricaDecreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia.Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South AfricaA systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis.The challenge of sustaining effectiveness over time: the case of the global network to stop tuberculosisNew strain multidrug resistant tuberculosis G24767 in Puerto Rico: Old disease a continuous threatCost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium.Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates.Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy.[Proposal of anti-tuberculosis regimens based on susceptibility to isoniazid and rifampicin].A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis.
P2860
Q26823223-DCF2A034-A009-4828-A09E-CAB7916FAFE0Q28397917-4C6C8287-8A8B-440D-9547-07F95A6F7429Q28478045-1A3E0AC6-D578-4FE4-82B3-D7C903DF54B9Q28484917-C4814D0D-C768-4D75-82BB-532A6869B5DEQ28534773-0556668D-12A0-4EBA-AD16-D0C7AF3FC277Q28551909-161CD60B-CF80-4F7B-B761-AD69B8A887EEQ30386148-342E7D34-8DB1-468C-BB18-56539F14B027Q33661518-B07E5B4C-421A-4CC5-8C99-CADC5B639DADQ33743201-B6971DE3-2798-4DAA-B10E-8B109FB8D546Q33862234-12B2E65A-711A-42F1-A1E5-AC6781B8FDD3Q33982095-45D33E80-C2FD-44B8-B709-32B60051AB2CQ34231472-841B3A47-1DDE-4125-8B2B-CF954EE3FA48Q34450210-C399EBD5-E021-47D0-9C3E-5452DE9A92DDQ34660618-ABFEDF87-EE5B-467E-B193-915F219399BFQ34778235-F7BB5D1D-F347-495B-BC30-4C006864CE64Q35014534-12F5E786-74C4-4AA7-ABAA-51C7E712FD0AQ35056793-17CFD784-37F9-4D68-8B16-D6D1B576FC68Q35084389-D8216E53-6AD1-4998-A698-9B293D90D9B1Q35129500-C18B76A2-9F2D-4004-A4F3-60A87AE1555DQ35181935-1D81D7FF-B04D-4A89-BE0C-72D70BCA296EQ35205113-10C44F32-EABC-46D1-AFA6-F7A13920FC43Q35344151-2B2FFB39-2C4F-41CC-A40C-F38DDEE6D3ACQ35590223-A1A7053A-7519-44F0-AA33-C29AD1236737Q35715390-4357AE2D-3BF0-410D-B6C5-E05D6C9D95FCQ35769140-56B8C8EC-75CE-43DD-A1D9-AC6435DED74DQ35825395-6856AD54-F8BE-4DA0-8850-CA11E8B851CFQ35843178-77B29256-8AC7-4855-B87C-60B8FF3FB2DEQ36018561-697C9E1A-E46E-42B2-9617-FFE2B38182F2Q36112155-C5132F09-D614-46E8-BBF2-9F47E77592BCQ36471055-07595F20-B112-4215-B946-CDA41DA8BE83Q36617071-255912E9-2662-4622-8206-AF3D39D1CA1AQ37026504-4A9EAF8E-64BD-4CBC-8131-F0C839D06BCFQ37089599-FBA4CCF6-5A8D-4C94-AAE0-CD6642AE8E18Q37111993-85E32383-D7B5-44DB-873F-9CBC40B705ACQ37171588-B5C4C1DA-8C51-4EFB-B2FB-8DBAA59A1F9FQ37529439-968546FC-358A-4D67-A84F-B3FFA5F5F9E8Q37546295-050017B8-EF1F-4EDF-A182-A39DB6814EF5Q37669577-2073174A-8A95-4D6E-8567-69B20280B96DQ37724770-3B00DEBF-0769-44B5-AA82-46C3D2A1EAABQ37954377-80A36B4E-DB9E-4AAC-A874-D7AFF1564270
P2860
MDR tuberculosis--critical steps for prevention and control.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MDR tuberculosis--critical steps for prevention and control.
@ast
MDR tuberculosis--critical steps for prevention and control.
@en
MDR tuberculosis--critical steps for prevention and control.
@nl
type
label
MDR tuberculosis--critical steps for prevention and control.
@ast
MDR tuberculosis--critical steps for prevention and control.
@en
MDR tuberculosis--critical steps for prevention and control.
@nl
prefLabel
MDR tuberculosis--critical steps for prevention and control.
@ast
MDR tuberculosis--critical steps for prevention and control.
@en
MDR tuberculosis--critical steps for prevention and control.
@nl
P2093
P356
P1476
MDR tuberculosis--critical steps for prevention and control.
@en
P2093
Diana Weil
Ernesto Jaramillo
Eva Nathanson
Katherine Floyd
Mukund Uplekar
P304
P356
10.1056/NEJMRA0908076
P407
P577
2010-09-01T00:00:00Z